Rahul Aggarwal
Clinical trials sponsored by Rahul Aggarwal, explained in plain language.
-
Can a tracer that hunts unstable iron light up hidden tumors?
Diagnosis Recruiting nowThis phase 1 trial is testing whether a new imaging tracer called 18F-TRX can safely and effectively detect solid tumors using PET scans. The tracer targets unstable iron levels, which are often elevated in cancerous tissue. Adults with advanced solid tumors, including certain pr…
Phase: PHASE1 • Sponsor: Rahul Aggarwal • Aim: Diagnosis
Last updated Jul 25, 2026 00:00 UTC
-
New imaging agent could reveal which cancers respond to immunotherapy
Diagnosis Recruiting nowThis phase I/II trial tests a radioactive tracer called 64Cu-GRIP B, which targets granzyme B—a substance released by immune cells. By using PET scans, researchers hope to see immune activity in tumors and predict whether immunotherapy will work. The study involves about 91 adult…
Phase: PHASE1, PHASE2 • Sponsor: Rahul Aggarwal • Aim: Diagnosis
Last updated Jun 27, 2026 11:03 UTC